MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
164.67M
P/E Ratio
N/A
Total Cash
165.49M
Projected Growth
N/A
Total Debt
5.43M
Revenue
27.31M
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
1.65
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
Fundamentals
ACIU
Capitalization
165M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
165M
Total Cash/Share
1.65
Total Debt
5.43M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.33%
Revenue
27.3M
ROE
N/A
Book Value
112M
P/B Ratio
1.22
Cash Flow
N/A
Earnings
-0.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.23M
Current Ratio
1.71
Current Revenue Per Employee
7062.11
Dividends Per Share - Security
N/A
EBITDA
-48.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.61
Shares Held By Institutions
78.8M
Shares Outstanding - Current
100M
Total Liabilities
119M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.259
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com